HomeIVBXF • OTCMKTS
add
Innovent Biologics Inc
Previous close
$11.14
Day range
$10.34 - $11.00
Year range
$3.91 - $15.12
Market cap
138.53B HKD
Avg Volume
1.66K
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
In the news
Financials
Income Statement
Revenue
Net income
| (CNY) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 2.98B | 50.62% |
Operating expense | 1.91B | 16.28% |
Net income | 417.16M | 312.50% |
Net profit margin | 14.01 | 241.09% |
Earnings per share | — | — |
EBITDA | 514.79M | 513.71% |
Effective tax rate | 7.00% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 9.54B | 10.56% |
Total assets | 23.59B | 16.25% |
Total liabilities | 9.17B | 16.56% |
Total equity | 14.42B | — |
Shares outstanding | 1.65B | — |
Price to book | 1.28 | — |
Return on assets | 4.10% | — |
Return on capital | 5.43% | — |
Cash Flow
Net change in cash
| (CNY) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 417.16M | 312.50% |
Cash from operations | 156.88M | 245.51% |
Cash from investing | 272.40M | 198.39% |
Cash from financing | 324.21M | 348.61% |
Net change in cash | 748.48M | 245.09% |
Free cash flow | 377.17M | 233.09% |
About
CEO
Founded
Apr 28, 2011
Website
Employees
6,190
